111 related articles for article (PubMed ID: 10772639)
21. Dependency of cyclosporine tissue distribution and metabolism on the age and gender of rats after a single intravenous dose.
Molpeceres J; Chacón M; Guzmán M; Aberturas MR; Berges L
Int J Pharm; 2000 Mar; 197(1-2):129-41. PubMed ID: 10704800
[TBL] [Abstract][Full Text] [Related]
22. Determination of initial i.v. CYA dosage to achieve target AUC values in pediatric hematopoietic stem cell transplant patients.
Jin M; Seto W; Taylor T; Saunders EF; Doyle J; Dupuis LL
Bone Marrow Transplant; 2008 Oct; 42(7):455-9. PubMed ID: 18622423
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics and brain uptake of AM-36, a novel neuroprotective agent, following intravenous administration to rats.
Nicolazzo JA; Nguyen TT; Katneni K; Steuten JA; Smith G; Jarrott B; Callaway JK; Charman SA
J Pharm Pharmacol; 2008 Feb; 60(2):171-8. PubMed ID: 18237464
[TBL] [Abstract][Full Text] [Related]
24. Effects of ezetimibe on cyclosporine pharmacokinetics in healthy subjects.
Bergman AJ; Burke J; Larson P; Johnson-Levonas AO; Reyderman L; Statkevich P; Kosoglou T; Greenberg HE; Kraft WK; Frick G; Murphy G; Gottesdiener K; Paolini JF
J Clin Pharmacol; 2006 Mar; 46(3):321-7. PubMed ID: 16490808
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic changes of intravenous tacrolimus in rats with uranyl nitrate-induced acute renal failure.
Son IJ; Moon YJ; Lee MG; Sohn YT
Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):359-68. PubMed ID: 11958289
[TBL] [Abstract][Full Text] [Related]
26. Marked decrease of cyclosporin bioavailability caused by coadministration of ginkgo and onion in rats.
Yang CY; Chao PD; Hou YC; Tsai SY; Wen KC; Hsiu SL
Food Chem Toxicol; 2006 Sep; 44(9):1572-8. PubMed ID: 16762474
[TBL] [Abstract][Full Text] [Related]
27. Dose-dependent pharmacokinetics of a new Na+/H+ exchanger inhibitor KR-33028 in rats.
Kim YH; Yoo SD; Kim YS; Lee KH; Lee HS
Biopharm Drug Dispos; 2007 Nov; 28(8):423-9. PubMed ID: 17828714
[TBL] [Abstract][Full Text] [Related]
28. Cyclosporin twice or three times daily dosing in pediatric transplant patients - it is not the same!
Filler G; de Barros VR; Jagger JE; Christians U
Pediatr Transplant; 2006 Dec; 10(8):953-6. PubMed ID: 17096765
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics, pharmacodynamics, and safety of inhaled cyclosporin A (ADI628) after single and repeated administration in healthy male and female subjects and asthmatic patients.
Rohatagi S; Calic F; Harding N; Ozoux ML; Bouriot JP; Kirkesseli S; DeLeij L; Jensen BK
J Clin Pharmacol; 2000 Nov; 40(11):1211-26. PubMed ID: 11075307
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and tissue distribution of novel traditional Chinese medicine-platinum anticancer agents in rats.
Wang X; Au-Yeung SC; Ho YP
J Inorg Biochem; 2007 Jun; 101(6):909-17. PubMed ID: 17428541
[TBL] [Abstract][Full Text] [Related]
31. Increased cyclosporine bioavailability induced by experimental nephrotic syndrome in rats.
Medeiros M; Pérez-Urizar J; Pedraza-Chaverri J; Muñoz-Arizpe R; Castañeda-Hernández G
Can J Physiol Pharmacol; 2007 May; 85(5):502-6. PubMed ID: 17632584
[TBL] [Abstract][Full Text] [Related]
32. Tissue distribution kinetics of a new nonsteroidal 5 alpha-reductase [correction of 5 A-reductase] inhibitor, 4-[3-[3-[bis(4-isobutylphenyl)methylamino]benzoyl]-1H-indol-1-YL ]-butyric acid, in rats.
Katashima M; Yamamoto K; Haraguchi K; Tokuma Y; Hata T; Sawada Y; Iga T
Drug Metab Dispos; 1997 Sep; 25(9):1051-8. PubMed ID: 9311620
[TBL] [Abstract][Full Text] [Related]
33. Effect of the six-mer synthetic peptide (AT1002) fragment of zonula occludens toxin on the intestinal absorption of cyclosporin A.
Song KH; Fasano A; Eddington ND
Int J Pharm; 2008 Mar; 351(1-2):8-14. PubMed ID: 17954018
[TBL] [Abstract][Full Text] [Related]
34. Mechanism for the nonlinear pharmacokinetics of erythropoietin in rats.
Kato M; Kamiyama H; Okazaki A; Kumaki K; Kato Y; Sugiyama Y
J Pharmacol Exp Ther; 1997 Nov; 283(2):520-7. PubMed ID: 9353365
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of appropriate blood level in continuous intravenous infusion from trough concentrations after oral administration based on area under trough level in tacrolimus and cyclosporine therapy.
Nakamura Y; Takeuchi H; Okuyama K; Akashi T; Jojima Y; Konno O; Akashi I; Hama K; Iwahori T; Ashizawa T; Hirano T; Oka K; Matsuno N; Nagao T
Transplant Proc; 2005 May; 37(4):1725-7. PubMed ID: 15919445
[TBL] [Abstract][Full Text] [Related]
36. Influence of intravenous methylprednisolone pulse treatment on the disposition of ciclosporin and hepatic CYP3A activity in rats.
Konishi H; Sumi M; Shibata N; Takada K; Minouchi T; Yamaji A
J Pharm Pharmacol; 2004 Apr; 56(4):477-83. PubMed ID: 15099443
[TBL] [Abstract][Full Text] [Related]
37. Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution.
Aliabadi HM; Brocks DR; Lavasanifar A
Biomaterials; 2005 Dec; 26(35):7251-9. PubMed ID: 16005061
[TBL] [Abstract][Full Text] [Related]
38. Toxicokinetics of lambda-cyhalothrin in rats.
Anadón A; Martínez M; Martínez MA; Díaz MJ; Martínez-Larrañaga MR
Toxicol Lett; 2006 Aug; 165(1):47-56. PubMed ID: 16513299
[TBL] [Abstract][Full Text] [Related]
39. [The effect of tetramethylpyrazine on the pharmacokinetics of intragastrically administered cyclosporine A in rats].
Liu XL; Tang J; Song J; He J; Xu P; Peng WX
Yao Xue Xue Bao; 2006 Sep; 41(9):882-7. PubMed ID: 17111838
[TBL] [Abstract][Full Text] [Related]
40. Time-dependent changes in cyclosporine exposure: implications for achieving target concentrations.
Felipe CR; Silva HT; Machado PG; Garcia R; Moreira SR; Pestana JO
Transpl Int; 2003 Jul; 16(7):494-503. PubMed ID: 12677364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
